Annual report pursuant to Section 13 and 15(d)

Supplemental Disclosure for Statements of Cash Flows (Details)

v2.4.0.8
Supplemental Disclosure for Statements of Cash Flows (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Platinum Montaur Life Sciences Llc Credit Facility [Member]
Dec. 31, 2013
Preferred Stock [Member]
Cash paid during the period for interest $ 1,900,000 $ 647,000 $ 4,000    
Stock Issued During Period, Shares, Issued for Milestone Fee 100,000        
Issued stock for payment of sublicense fee, shares   300,000      
Issued stock to 401(k) plan, shares 22,126 17,390 35,233    
Value of inventory transferred to fixed assets     25,000    
Portion of insurance premiums financed   267,000      
Debt Instrument, Interest Rate, Stated Percentage   2.80%   10.00%  
Equipment acquired under capital lease agreement   9,000      
Stock Issued During Period, Shares, Conversion of Convertible Securities         2,364.9
Repayments of Notes Payable $ 5,982,155 $ 1,285,046 $ 62,411 $ 4,800,000